Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Sex-specific Associations of Aldosterone and Renin With Body Composition: A Population-based Cohort Study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context

          Renin–angiotensin–aldosterone system (RAAS) activation is closely linked to obesity; however, the sex-specific associations between RAAS activity and body composition among individuals without obesity are not well understood.

          Objective

          To investigate the associations of aldosterone and renin with body composition according to sex in the general population.

          Design

          Population-based cohort study.

          Setting

          Québec (Canada).

          Participants

          Adults aged 40 to 69 years enrolled in CARTaGENE between 2009 and 2010 (N = 3687).

          Exposures

          Plasma aldosterone and renin concentrations.

          Main Outcome Measures

          Body composition assessed via anthropometrics (waist circumference and waist-to-hip ratio), bioelectrical impedance (lean body mass, fat mass, and muscle mass), and cardiac magnetic resonance imaging (epicardial and pericardial adipose tissue volumes).

          Results

          The mean (SD) age and body mass index were 55 (8) years and 27.3 (4.8) kg/m 2, respectively. Among males, higher aldosterone and renin were associated with increased waist circumference, increased waist-to-hip ratio, increased fat mass, decreased lean body mass, and decreased muscle mass ( P < .05). Aldosterone ( P = .02), but not renin ( P = .43), was associated with increased ectopic cardiac adiposity in males. In contrast, higher renin ( P < .05), but not aldosterone ( P ≥ .05), was associated with increased waist circumference, increased waist-to-hip ratio, and increased cardiac adiposity in females. Among females, higher renin and aldosterone were associated with increased fat mass ( P < .05) but were not associated with lean body mass or muscle mass ( P ≥ .05). All aforementioned associations were independent of body weight.

          Conclusion

          Independent of body weight, increased RAAS activity is associated with unfavorable differences in body composition; however, the strength and pattern of association varies by sex.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: not found

          Waist circumference and not body mass index explains obesity-related health risk.

          The addition of waist circumference (WC) to body mass index (BMI; in kg/m(2)) predicts a greater variance in health risk than does BMI alone; however, whether the reverse is true is not known. We evaluated whether BMI adds to the predictive power of WC in assessing obesity-related comorbidity. Subjects were 14 924 adult participants in the third National Health and Nutrition Examination Survey, grouped into categories of BMI and WC in accordance with the National Institutes of Health cutoffs. Odds ratios for hypertension, dyslipidemia, and the metabolic syndrome were compared for overweight and class I obese BMI categories and the normal-weight category before and after adjustment for WC. BMI and WC were also included in the same regression model as continuous variables for prediction of the metabolic disorders. With few exceptions, overweight and obese subjects were more likely to have hypertension, dyslipidemia, and the metabolic syndrome than were normal-weight subjects. After adjustment for WC category (normal or high), the odds of comorbidity, although attenuated, remained higher in overweight and obese subjects than in normal-weight subjects. However, after adjustment for WC as a continuous variable, the likelihood of hypertension, dyslipidemia, and the metabolic syndrome was similar in all groups. When WC and BMI were used as continuous variables in the same regression model, WC alone was a significant predictor of comorbidity. WC, and not BMI, explains obesity-related health risk. Thus, for a given WC value, overweight and obese persons and normal-weight persons have comparable health risks. However, when WC is dichotomized as normal or high, BMI remains a significant predictor of health risk.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bioelectrical impedance analysis--part I: review of principles and methods.

            U KYLE (2004)
            The use of bioelectrical impedance analysis (BIA) is widespread both in healthy subjects and patients, but suffers from a lack of standardized method and quality control procedures. BIA allows the determination of the fat-free mass (FFM) and total body water (TBW) in subjects without significant fluid and electrolyte abnormalities, when using appropriate population, age or pathology-specific BIA equations and established procedures. Published BIA equations validated against a reference method in a sufficiently large number of subjects are presented and ranked according to the standard error of the estimate. The determination of changes in body cell mass (BCM), extra cellular (ECW) and intra cellular water (ICW) requires further research using a valid model that guarantees that ECW changes do not corrupt the ICW. The use of segmental-BIA, multifrequency BIA, or bioelectrical spectroscopy in altered hydration states also requires further research. ESPEN guidelines for the clinical use of BIA measurements are described in a paper to appear soon in Clinical Nutrition.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              2020 International Society of Hypertension global hypertension practice guidelines

                Bookmark

                Author and article information

                Contributors
                Journal
                J Clin Endocrinol Metab
                J Clin Endocrinol Metab
                jcem
                The Journal of Clinical Endocrinology and Metabolism
                Oxford University Press (US )
                0021-972X
                1945-7197
                March 2025
                16 August 2024
                16 August 2024
                : 110
                : 3
                : 801-810
                Affiliations
                Department of Medicine, Division of Nephrology, University of Ottawa , Ottawa, ON K1H 7W9, Canada
                Ottawa Hospital Research Institute , Ottawa, ON K1Y 4E9, Canada
                Department of Medicine, Division of Nephrology, CHU de Québec-Université Laval , Quebec City, QC G1R 3S1, Canada
                Department of Medicine, Division of Nephrology, Hôpital du Sacré-Coeur de Montréal, Université de Montréal , Montreal, QC H3C 3J7, Canada
                Department of Medicine, Division of Cardiology, Université Laval , Quebec City, QC G1V 0A6, Canada
                Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval , Quebec City, QC G1V 4G5, Canada
                Department of Medicine, Division of Endocrinology, CHU de Québec-Université Laval , Quebec City, QC G1V 4G2, Canada
                Department of Medicine, Division of Endocrinology, University of Sherbrooke , Sherbrooke, QC J1H 5H3, Canada
                Department of Medicine, Division of Endocrinology, University of Sherbrooke , Sherbrooke, QC J1H 5H3, Canada
                Department of Medicine, Division of Endocrinology and Metabolism, Cumming School of Medicine, University of Calgary , Calgary, AB T2N 1N4, Canada
                Department of Community Health Sciences, Cumming School of Medicine, University of Calgary , Calgary, AB T2N 1N4, Canada
                Department of Medicine, Division of Endocrinology and Metabolism, Cumming School of Medicine, University of Calgary , Calgary, AB T2N 1N4, Canada
                Department of Medicine, Division of Nephrology, University of Ottawa , Ottawa, ON K1H 7W9, Canada
                Ottawa Hospital Research Institute , Ottawa, ON K1Y 4E9, Canada
                Department of Medicine, Division of Nephrology, University of Ottawa , Ottawa, ON K1H 7W9, Canada
                Ottawa Hospital Research Institute , Ottawa, ON K1Y 4E9, Canada
                Ottawa Hospital Research Institute , Ottawa, ON K1Y 4E9, Canada
                Department of Medicine, Division of Nephrology, Hôpital du Sacré-Coeur de Montréal, Université de Montréal , Montreal, QC H3C 3J7, Canada
                Author notes
                Correspondence: Gregory L. Hundemer, MD, MPH, Department of Medicine, Division of Nephrology, University of Ottawa, 1967 Riverside Drive, Office 5-33, Ottawa, ON K1H 7W9, Canada. Email: ghundemer@ 123456toh.ca .
                Author information
                https://orcid.org/0000-0003-3559-3531
                https://orcid.org/0000-0001-9623-962X
                https://orcid.org/0000-0001-9791-2118
                https://orcid.org/0000-0002-8129-9360
                https://orcid.org/0000-0003-3951-2911
                https://orcid.org/0000-0001-8478-8170
                Article
                dgae566
                10.1210/clinem/dgae566
                11834704
                39148442
                aad2c463-e42e-4833-bb39-e036c0e3e4fa
                © The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. See the journal About page for additional terms.

                History
                : 13 June 2024
                : 13 August 2024
                : 04 September 2024
                Page count
                Pages: 10
                Funding
                Funded by: Kidney Foundation of Canada, DOI 10.13039/501100000191;
                Award ID: 851937-21KHRG
                Funded by: Heart and Stroke Foundation of Canada New Investigator Award, DOI 10.13039/501100000222;
                Funded by: Fonds de Recherche du Québec Santé, DOI 10.13039/501100000156;
                Funded by: Canadian Institutes of Health Research, DOI 10.13039/501100000024;
                Award ID: PJT-173313
                Award ID: PJT-175027
                Funded by: Heart and Stroke Foundation of Canada, DOI 10.13039/100004411;
                Award ID: G-20-0028656
                Funded by: Fonds de Recherche du Québec Santé, and the Société québécoise d’hypertension artérielle—Bourse Jacques-de-Champlain;
                Categories
                Clinical Research Article
                AcademicSubjects/MED00250

                Endocrinology & Diabetes
                aldosterone,renin,adiposity,body fat,body composition,sex
                Endocrinology & Diabetes
                aldosterone, renin, adiposity, body fat, body composition, sex

                Comments

                Comment on this article